An Evaluation of the Cost-Effectiveness of Rituximab in Combination with Chemotherapy for the First-Line Treatment of Follicular Non-Hodgkin's Lymphoma in the UK

Joshua A. Ray*, Emma Carr, Gavin Lewis, Robert Marcus

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    31 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'An Evaluation of the Cost-Effectiveness of Rituximab in Combination with Chemotherapy for the First-Line Treatment of Follicular Non-Hodgkin's Lymphoma in the UK'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science